COMP <GO>
OPRX vs V // ENTERPRISE SCALE & MARKET CAP
OptimizeRx Corporation (NASDAQ) VS. Visa Inc. (NYSE) • 15-METRIC TALLY: OPRX 4
— V 7
▲ ENTERPRISE SCALE & MARKET CAP LEADER: V
LAST: $9.37 (+0.75%) • MKT CAP: $176.5M
market-cap
$176.5M
LAST: $410.54 (+2.48%) • MKT CAP: $733.53B
market-cap
$733.53B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OPRX VS. V)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | OPRX | V | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.30% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.30% | 32.30% | -25.00 | V | /roic <GO> |
| EV/EBITDA & P/E Valuation | 14.9x | 28.9x | -14.00 | OPRX | /valuation <GO> |
| Free Cash Flow Yield | 10.57% | 2.90% | +7.67 | OPRX | /fcf-yield <GO> |
| Operating Margin | 10.70% | 60.00% | -49.30 | V | /operating-margins <GO> |
| Net Profit Margin | 4.70% | 50.10% | -45.40 | V | /net-margins <GO> |
| Revenue Growth (YoY) | 18.80% | 11.30% | +7.50 | OPRX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.63% | -0.63 | V | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.68 | 9.09 | -6.41 | V | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 9/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 63.6 | 65.6 | -2.04 | V | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 1.06 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 28.9x | 34.0x | -5.10 | OPRX | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $176.5M | $733.53B | -$733.36B | V | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | OPRX REV | V REV | OPRX GROSS % | V GROSS % | OPRX FCF | V FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $109.4M | $40.00B | 67.3% | — | $18.7M | $21.26B |
| FY 2024 | $92.1M | $35.93B | 64.5% | — | $4.8M | $18.33B |
| FY 2023 | $71.5M | $32.65B | — | — | -$7.2M | $19.29B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OPRX // BETA —
V // BETA 1.06